Max Robotics — Global Service Robot Directory + US Certification

About

Ketti Mazzocco is a leading researcher in psycho-oncology and health-related quality of life (QoL), with a particular focus on surgical oncology and patient-reported outcomes. Her work centers on understanding how cancer patients—especially those undergoing robotic-assisted surgeries for prostate, breast, and lung cancers—experience and recover from treatment. Mazzocco’s major contributions include identifying longitudinal trajectories of recovery, such as predicting patterns of urinary and sexual dysfunction in prostate cancer patients after Robot-Assisted Radical Prostatectomy (RARP), and mapping one-year QoL trends in early-stage lung cancer patients post-lobectomy. She has also been instrumental in validating critical psychometric tools for Italian populations, including the EPIC-26 (for prostate cancer) and the EORTC QLQ-C30 (for lung cancer), ensuring culturally appropriate and reliable measurement of QoL. Her most-cited papers, each garnering 15–22 citations, reflect her impact on evidence-based, patient-centered care. Notably, her 2015 preliminary report on robotic nipple-sparing mastectomy with immediate reconstruction highlights her interest in surgical innovation. Mazzocco’s work bridges clinical outcomes and psychological well-being, offering actionable insights for personalized recovery pathways.